CSI Market
Sign In | Register

Cadence Pharmaceuticals Inc (CADX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CADX Annual Cash Flow →
Examining cash flow movements between Cadence Pharmaceuticals Inc and Sep 30 2012 reveals how Sep 30 2013 allocates cash as operating conditions evolve.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2013)
9 Months 		(Jun 30 2013) (Mar 31 2013) (Dec 31 2012) (Sep 30 2012)
Operating Activities
Income-20.18
Depreciation & amortization0.17
Amortization of Other Assets1.39
Increase (Decrease) in Deferred Revenue-2.23
Impairment of Long-Lived Assets Held-for-use0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.40
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property-0.02
Share-based Compensation5.33
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Income taxes0.00
Gain (Loss) on Sale of Investments-7.65
Increase (Decrease) in Accounts Receivable-2.56
Increase (Decrease) in Accounts Payable-1.32
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.14
Other Working Capital2.98
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-23.84
Investing Activities
Capital Expenditures-0.08
Sale of Capital Items0.08
Short-term Investments Proceeds16.07
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities16.07
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock1.42
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.42
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-23.84
Total Cash Flow-6.35
4 historic quarters locked

Sign in to unlock the full Cadence Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About CADX Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Get the full CSIMarket dataset: Subscribe API Connect Your AI